Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer.

Genome-wide measures of gene expression can identify patterns of gene activity that subclassify tumours and might provide better means than are currently available for individual risk assessment in patients with primary breast cancer and for prediction of tamoxifen resistance.